IgG4相关疾病-话题@MedSci - 梅斯（MedSci）

#IgG4相关疾病#

7篇内容 | 1085人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2226144, encodeId=c62c2226144a7, content=<a href='/topic/show?id=2de3951465' target=_blank style='color:#2F92EE;'>#IgG4相关疾病#</a>, objectTitle=Arthritis Res Ther：日本一般人群中血清IgG4水平升高的流行情况及相关因素, objectType=article, longId=843598, objectId=f51f84359853, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240916/1726480280131_5485250.jpg, objectUrl=/article/show_article.do?id=f51f84359853, replyNumber=0, likeNumber=51, createdTime=2024-09-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f51f84359853, moduleTitle=Arthritis Res Ther：日本一般人群中血清IgG4水平升高的流行情况及相关因素, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f51f84359853)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1598948, encodeId=a040159894827, content=<a href='/topic/show?id=2de3951465' target=_blank style='color:#2F92EE;'>#IgG4相关疾病#</a>, objectTitle=A&R：CD163+ M2巨噬细胞通过Toll样受体7/IL-1受体相关激酶4/NF-κB信号通路促进IgG4相关疾病的纤维化, objectType=article, longId=726552, objectId=259ee265523c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=259ee265523c, replyNumber=0, likeNumber=75, createdTime=2022-05-12, rootId=0, userName=jiekemin, userId=43c618641271, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=259ee265523c, moduleTitle=A&R：CD163+ M2巨噬细胞通过Toll样受体7/IL-1受体相关激酶4/NF-κB信号通路促进IgG4相关疾病的纤维化, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=259ee265523c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598947, encodeId=0d1a159894e97, content=<a href='/topic/show?id=2de3951465' target=_blank style='color:#2F92EE;'>#IgG4相关疾病#</a>, objectTitle=免费回放：IgG4相关疾病的规范诊治, objectType=article, longId=294312, objectId=97af294312c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97af294312c9, replyNumber=0, likeNumber=56, createdTime=2022-01-21, rootId=0, userName=jiekemin, userId=43c618641271, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97af294312c9, moduleTitle=免费回放：IgG4相关疾病的规范诊治, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=97af294312c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598946, encodeId=cf921598946cd, content=<a href='/topic/show?id=2de3951465' target=_blank style='color:#2F92EE;'>#IgG4相关疾病#</a>, objectTitle=NEJM：IgG4相关疾病中的冠状动脉炎-病例报道, objectType=article, longId=167190, objectId=146f16e190b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=146f16e190b4, replyNumber=0, likeNumber=78, createdTime=2019-06-01, rootId=0, userName=jiekemin, userId=43c618641271, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=146f16e190b4, moduleTitle=NEJM：IgG4相关疾病中的冠状动脉炎-病例报道, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=146f16e190b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598945, encodeId=cf9a159894553, content=<a href='/topic/show?id=2de3951465' target=_blank style='color:#2F92EE;'>#IgG4相关疾病#</a>, objectTitle=Exp Ther Med：眼眶IgG4相关疾病的临床观察, objectType=article, longId=159301, objectId=93491593013a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93491593013a, replyNumber=0, likeNumber=75, createdTime=2019-02-02, rootId=0, userName=jiekemin, userId=43c618641271, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93491593013a, moduleTitle=Exp Ther Med：眼眶IgG4相关疾病的临床观察, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=93491593013a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598944, encodeId=8d9c15989447e, content=<a href='/topic/show?id=2de3951465' target=_blank style='color:#2F92EE;'>#IgG4相关疾病#</a>, objectTitle=“IgG4相关疾病”得到明确——它让一些“癌症病人”得到昭雪, objectType=article, longId=115496, objectId=231e11549640, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=231e11549640, replyNumber=0, likeNumber=93, createdTime=2017-10-11, rootId=0, userName=jiekemin, userId=43c618641271, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=231e11549640, moduleTitle=“IgG4相关疾病”得到明确——它让一些“癌症病人”得到昭雪, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=231e11549640)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598943, encodeId=d53d1598943bf, content=<a href='/topic/show?id=2de3951465' target=_blank style='color:#2F92EE;'>#IgG4相关疾病#</a>, objectTitle=Curr Opin Ophthalmol：眼睛及附属器官中的IgG4相关疾病综述！, objectType=article, longId=111738, objectId=c764111e3872, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c764111e3872, replyNumber=0, likeNumber=77, createdTime=2017-09-04, rootId=0, userName=jiekemin, userId=43c618641271, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c764111e3872, moduleTitle=Curr Opin Ophthalmol：眼睛及附属器官中的IgG4相关疾病综述！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c764111e3872)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1598942, encodeId=26341598942a8, content=<a href='/topic/show?id=2de3951465' target=_blank style='color:#2F92EE;'>#IgG4相关疾病#</a>, objectTitle=国际IgG4相关疾病管理与治疗的共识出台, objectType=article, longId=76750, objectId=c204e6750f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c204e6750f7, replyNumber=0, likeNumber=75, createdTime=2016-09-08, rootId=0, userName=jiekemin, userId=43c618641271, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c204e6750f7, moduleTitle=国际IgG4相关疾病管理与治疗的共识出台, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c204e6750f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

IgG4相关疾病

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#IgG4相关疾病#

Arthritis Res Ther：日本一般人群中血清IgG4水平升高的流行情况及相关因素

2024-09-16发表于上海

jiekemin (审核中...)

前往app查看评论内容

#IgG4相关疾病#

A&R：CD163+ M2巨噬细胞通过Toll样受体7/IL-1受体相关激酶4/NF-κB信号通路促进IgG4相关疾病的纤维化

2022-05-12

jiekemin (审核中...)

前往app查看评论内容

#IgG4相关疾病#

免费回放：IgG4相关疾病的规范诊治

2022-01-21

jiekemin (审核中...)

前往app查看评论内容

#IgG4相关疾病#

NEJM：IgG4相关疾病中的冠状动脉炎-病例报道

2019-06-01

jiekemin (审核中...)

前往app查看评论内容

#IgG4相关疾病#

Exp Ther Med：眼眶IgG4相关疾病的临床观察

2019-02-02

jiekemin (审核中...)

前往app查看评论内容

#IgG4相关疾病#

“IgG4相关疾病”得到明确——它让一些“癌症病人”得到昭雪

2017-10-11

jiekemin (审核中...)

前往app查看评论内容

#IgG4相关疾病#

Curr Opin Ophthalmol：眼睛及附属器官中的IgG4相关疾病综述！

2017-09-04

jiekemin (审核中...)

前往app查看评论内容

#IgG4相关疾病#

国际IgG4相关疾病管理与治疗的共识出台

2016-09-08

科室
- - 订阅+
  - 更多科室
工具
服务